Andrew H. Wei, MBBS, PhD, on Oral Azacitidine as Maintenance Therapy in AML: Clinical Challenges

Posted: Sunday, March 1, 2020

Andrew H. Wei, MBBS, PhD, of The Alfred Hospital, Melbourne, talks about the clinical challenges of encouraging and monitoring adherence, managing side effects, and other issues relevant to treating older patients with acute myeloid leukemia.

---